Similar articles

• [Idiopathic thrombocytopenia refractery to therapy of cyclosporine A in clinical practice - case report].

  Schwarzová L, Pirník Z, Štecová N. Schwarzová L, et al. Ceska Slov Farm. 2018 Spring;66(5):233-237. Ceska Slov Farm. 2018. PMID: 29623717 Czech.
• Cyclosporin A in the treatment of refractory immune thrombocytopenia purpura in children.

  Gesundheit B, Cividalli G, Freeman A, Yatziv S, Koren G, Baruchel S. Gesundheit B, et al. Eur J Haematol. 2001 May;66(5):347-51. doi: 10.1034/j.1600-0609.2001.066005347.x. Eur J Haematol. 2001. PMID: 11422416
• The effect of treatment with Campath-1H in patients with autoimmune cytopenias.

  Willis F, Marsh JC, Bevan DH, Killick SB, Lucas G, Griffiths R, Ouwehand W, Hale G, Waldmann H, Gordon-Smith EC. Willis F, et al. Br J Haematol. 2001 Sep;114(4):891-8. doi: 10.1046/j.1365-2141.2001.03039.x. Br J Haematol. 2001. PMID: 11564082
• Crohn's colitis and idiopathic thrombocytopenic purpura.

  Boyne MS, Dye KR. Boyne MS, et al. Postgrad Med J. 2000 May;76(895):299-300. doi: 10.1136/pmj.76.895.299. Postgrad Med J. 2000. PMID: 10775285 Free PMC article. Review.
• Targeted ITP strategies: do they elucidate the biology of ITP and related disorders?

  Bennett CM, de Jong JL, Neufeld EJ. Bennett CM, et al. Pediatr Blood Cancer. 2006 Oct 15;47(5 Suppl):706-9. doi: 10.1002/pbc.20974. Pediatr Blood Cancer. 2006. PMID: 16933263 Review.